J. Mehta

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Jawahar Jay L Mehta, Jawahar L. Mehta, J. L. Mehta, J Mehta, J.l. Mehta, J L Mehta, Jawahar Mehta, Jawahar L Mehta, Jawahar Lal Mehta, J. Mehta
Publication record
823 papers · 41,562 citations · H-index 96

PAPERS

Proteomic analysis of transcription factors involved in the alteration of ischemic mouse heart as modulated by MSC exosomes
20232 citationsauthor #7
Protein homeostasis in the aged and diseased heart
20236 citationsauthor #5
438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease
20230 citationsauthor #4
Oxidized LDL receptors: a recent update
20239 citationsauthor #6
COVID-19 Vaccine-Induced Pro-thrombotic Immune Thrombocytopenia (VIPIT): State of the Art
20220 citationsauthor #6
Erratum to “How to treat left ventricular thrombi- Warfarin or direct oral anti-coagulants?” [Am. Heart J. Plus Cardiol. Res. Pract. 13 (January 2022) 100075]
20220 citationsauthor #3
PEGylated Gold Nanoparticle Toxicity in Cardiomyocytes: Assessment of Size, Concentration, and Time Dependency
20224 citationsauthor #5
Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
202210 citationsauthor #10
The structural basis of effective LOX-1 inhibition.
20222 citationsauthor #4
Author Correction: Molecular events in MSC exosome mediated cytoprotection in cardiomyocytes
20221 citationsauthor #7
Mini review article: LOX-1: IMPLICATIONS IN ATHEROSCLEROSIS AND MYOCARDIAL ISCHEMIA
20227 citationsauthor #3
Association of Lipid Levels With COVID-19 Infection, Disease Severity and Mortality: A Systematic Review and Meta-Analysis
202241 citationsauthor #7
Reducing Proteoglycan Synthesis and NOX Activity by ROCK Inhibitors: Therapeutic Targets in Atherosclerosis.
20226 citationsauthor #6
NLRP3 inflammasome via IL-1β regulates PCSK9 secretion: Erratum
20220 citationsauthor #9
Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis.
20227 citationsauthor #8
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
202259 citationsauthor #6
BROMOCRIPTINE USE IN PERIPARTUM CARDIOMYOPATHY:SYSTEMATIC REVIEW AND META ANALYSIS
20220 citationsauthor #6
NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
202268 citationsauthor #7
MSC exosome-mediated cardioprotection in ischemic mouse heart comparative proteomics of infarct and peri-infarct areas
202129 citationsauthor #6
Gender differences, outcomes and trends among nonagenarian with atrial fibrillation: insight from National Inpatient Sample database
20210 citationsauthor #8
Proteomic basis of modulation of post ischemic fibrosis by MSC exosomes.
20217 citationsauthor #6
IN-HOSPITAL OUTCOMES IN HEART FAILURE PATIENTS WITH HISTORY OF ANXIETY DISORDER: INSIGHT FROM THE NATIONWIDE INPATIENT SAMPLE DATABASE
20210 citationsauthor #8
Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines
202111 citationsauthor #5
Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19
202153 citationsauthor #2
Loneliness and Social Isolation: Determinants of Cardiovascular Outcomes
202120 citationsauthor #3
Hepatic Interactions in Atherosclerotic Heart Disease.
20215 citationsauthor #5
LOX-1 Deletion Attenuates Myocardial Fibrosis in the Aged Mice, Particularly Those With Hypertension
20219 citationsauthor #8
Corrigendum to: PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1.
202110 citationsauthor #5
Letter in response to “COVID‐19, Virchow's triad and thromboembolic risk in obese pregnant women”
20212 citationsauthor #3
Stress cardiomyopathy in patients with COVID-19 infection
20210 citationsauthor #4
Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis
20219 citationsauthor #7
Plant-Based Diet, Gut Microbiota, and Bioavailability of Lignans.
20215 citationsauthor #3
How to treat left ventricular thrombi- warfarin or direct oral anti-coagulants?
20211 citationsauthor #3
Corrigendum to: Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines.
20210 citationsauthor #8
Potent Antiplatelet Therapy May Reduce Death from Sepsis in Patients on Chronic Dialysis.
20218 citationsauthor #4
Does aspirin save lives in patients with COVID-19?
20216 citationsauthor #4
Cardiac Fibrosis Following Myocardial Ischemia is Mitigated by Mesenchymal Stem Cell Exosomes
20210 citationsauthor #5
Corrigendum to: PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy.
20212 citationsauthor #9
Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
202119 citationsauthor #5
Meta-analysis of the Effect of Colchicine on Mortality and Mechanical Ventilation in COVID-19
202124 citationsauthor #2
Corrigendum to: PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages.
20216 citationsauthor #9
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
20213,716 citationsauthor #1648
Implications of renal ACE2 expression in the age of COVID-19
20204 citationsauthor #3
Suicide, Depression, and Cardiovascular Disease.
20201 citationsauthor #1
Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications.
202012 citationsauthor #5
Ácido acetilsalicílico para la prevención primaria de eventos cardiovasculares
20200 citationsauthor #12
Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice
202026 citationsauthor #10
Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.
202094 citationsauthor #6
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection
202015 citationsauthor #5
Gender-Related Differences in the Pathogenesis and Diagnosis of Ischemic Heart Disease
20200 citationsauthor #4
COVID‐19, thromboembolic risk, and Virchow's triad: Lesson from the past
202052 citationsauthor #1
LOX‐1 is the prime target for mesenchymal stem cell exosome mediated cardioprotective effects
20200 citationsauthor #5
Aspirin for prevention of colorectal cancer in the elderly: friend or foe?
202011 citationsauthor #5
Takotsubo cardiomyopathy and COVID-19 infection
202026 citationsauthor #2
Daytime or Nighttime Administration of Antihypertensive Medications?
20205 citationsauthor #3
Utility of Inferior Lead Q-waveforms in diagnosing Ventricular Tachycardia
20202 citationsauthor #5
Heparan sulfate consumption as a potential mechanism of intra-cardiac thrombosis in SARS-CoV-2 infection
20204 citationsauthor #2
Insights on Kawasaki disease and multisystem inflammatory syndrome; relationship with COVID-19 infection.
202015 citationsauthor #2
Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19
202041 citationsauthor #2
Cardiac Arrhythmias and COVID-19 – a Meta-analysis of Recent Reports
20200 citationsauthor #2
NLRP3 inflammasome via IL-1β regulates PCSK9 secretion
202067 citationsauthor #9
Coronavirus disease 2019 infection and the cardiovascular system.
202011 citationsauthor #4
Different Faces of Obesity in Cardiovascular Diseases: Culprit or Protector
20200 citationsauthor #4
Advances in the molecular mechanisms of NLRP3 inflammasome activators and inacativators.
202075 citationsauthor #7
Smoking Doubles the Mortality Risk in COVID-19: A Meta-Analysis of Recent Reports and Potential Mechanisms
202047 citationsauthor #3
Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection
202016 citationsauthor #3
The Deadly Quartet (Covid-19, Old Age, Lung Disease, and Heart Failure) Explains Why Coronavirus-Related Mortality in Northern Italy Was So High
202014 citationsauthor #7
Artificial Intelligence, Machine Learning, and Cardiovascular Disease
2020148 citationsauthor #4
Blood flow patterns regulate PCSK9 secretion via MyD88 mediated proinflammatory cytokines.
201966 citationsauthor #8
Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis
201922 citationsauthor #7
Thiamine supplementation for acute heart failure patients
20190 citationsauthor #3
Abstract 555: Platelet Volume Indices as Markers of Platelet Reactivity in Atherosclerotic Coronary Artery Disease
20190 citationsauthor #6
LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
2019219 citationsauthor #3
BURDEN AND IMPACT OF ARRHYTHMIAS IN MARIJUANA USERS ACROSS THE UNITED STATES
20191 citationsauthor #5
Assessing medication adherence: a new quality metric?
20192 citationsauthor #2
BURDEN OF CARDIAC ARRHYTHMIAS IN SARCOIDOSIS: A NATIONWIDE ANALYSIS
20190 citationsauthor #5
Response to 'Late repercussions of assisted reproductive technology'.
20192 citationsauthor #1
Premature birth, infections, and atherosclerotic cardiovascular disease.
20193 citationsauthor #1
Abstract P135: Regional Differences in Epidemiology and Outcomes of Heart Failure Admissions Across the United States
20190 citationsauthor #3
Thiamin therapy for chronic heart failure: is there any future for this vitamin?
20199 citationsauthor #3
Aspirin for primary prevention in the elderly
20196 citationsauthor #3
Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs.
201912 citationsauthor #4
Role of Ox-LDL and LOX-1 in Atherogenesis.
2019284 citationsauthor #3
Epigenetic Modification in Coronary Atherosclerosis: JACC Review Topic of the Week.
201965 citationsauthor #5
Aspirin for Primary Prevention of Cardiovascular Events.
201994 citationsauthor #12
Blood pressure target in diabetics: how low is too low?
20192 citationsauthor #4
PCSK9 and inflammation: Role of shear stress, pro-inflammatory cytokines and LOX-1 4.
2019180 citationsauthor #5
Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood
201986 citationsauthor #6
Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis
20196 citationsauthor #8
Molecular events in MSC exosome mediated cytoprotection in cardiomyocytes
201922 citationsauthor #7
Oxidant Stress in Atherosclerosis: Oxidatively Modified LDL and LOX-1
20190 citationsauthor #2
MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1
201840 citationsauthor #5
Can certain infections protect against atherosclerosis?
20180 citationsauthor #2
Multiple admissions to the coronary care unit due to falsely elevated cardiac troponin
20186 citationsauthor #6
PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages
2018111 citationsauthor #8
Inflammation, Autophagy, and Apoptosis After Myocardial Infarction
2018196 citationsauthor #4
Abstract 17373: Prescription Patterns and Outcomes of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation a Real World Analysis
20180 citationsauthor #6
Mitochondrial Autophagy and NLRP3 Inflammasome in Pulmonary Tissues from Severe Combined Immunodeficient Mice after Cardiac Arrest and Cardiopulmonary Resuscitation
201810 citationsauthor #2
MANAGEMENT OF THROMBUS IN TRANSIT THROUGH A PATENT FORAMEN OVALE
20180 citationsauthor #3
PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy
2018123 citationsauthor #9

TIMELINE

1976 1 citations

1978 138 citations

1979 266 citations

1980 65 citations

1981 207 citations

1982 345 citations

1983 484 citations

1984 164 citations

1985 148 citations

1986 40 citations

1987 310 citations

1988 418 citations

1989 690 citations

1990 673 citations

1991 269 citations

1992 477 citations

1993 141 citations

1994 4,228 citations

1995 410 citations

1996 721 citations

1997 199 citations

1998 1,023 citations

1999 1,355 citations

2000 1,387 citations

2001 647 citations

2002 960 citations

2003 1,461 citations

2004 2,177 citations

2005 831 citations

2006 1,650 citations

2007 1,170 citations

2008 639 citations

2009 614 citations

2010 380 citations

2011 1,340 citations

2012 1,094 citations

2013 923 citations

2014 893 citations

2015 1,564 citations

2016 1,201 citations

2017 2,838 citations

2018 762 citations

2019 1,081 citations

2020 686 citations

2021 3,942 citations

2022 205 citations

2023 17 citations

J. Mehta

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT